Study of 10-year-old flu samples finds virus’s evolution in individual transplant patients partially mirrors later global trends
June 27, 2017
| By Rachel Tompa / Fred Hutch News Service
When it comes to the flu, a few infected people may speak for the multitude. Evolutionary biologists have found that evolution in individual infections has parallels to the virus's later global evolution.
Dr. Colleen Delaney leads first test of "off-the-shelf" cord blood cell product outside the transplant setting; Dr. Justin Taylor receives Hartwell Foundation award to research alternative to RSV vaccine
Antiviral drug for post-transplant complications now costs more than the transplant
June 2, 2016
| By Mary Engel / Fred Hutch News Service
A life-saving antiviral drug used to treat a type of severe pneumonia in children and adults who have undergone bone marrow transplants can now cost more than the transplant itself after the drug’s sole distributor, Valeant Pharmaceuticals, increased the price by almost 400 percent.